United States Artificial Cornea and Corneal Implants Market to Grow with an Impressive CAGR until 2026
Rising instances of eye
diseases is driving the growth of United States Artificial Cornea and Corneal
Implants Market, in the forecast period.
According to TechSci report on, “United
States Artificial
Cornea and Corneal Implants Market By Type (Human Cornea v/s Artificial Cornea) By
Transplant Type (Penetrating Keratoplasty v/s Endothelial Keratoplasty) By
Disease Indication (Fuchs’ Dystrophy, Keratoconus, Fungal Keratitis, Others) By
End User (Hospitals, Ambulatory Care Centers, Others) By Region, Competition
Forecast & Opportunities, 2026”, United States artificial cornea and corneal
implants market is projected
to show a robust growth with an impressive CAGR in the forecast period,
2022-2026 on the account of rising instances of eye diseases like Keratoconus,
fungal keratitis, etc.
Moreover,
the rising population being affected most by the eye diseases are expected to
drive the growth of the United States artificial cornea and corneal implants
market in the next five years. With the advanced technology and consistent
research and development, cost efficient
implants with biocompatibility and enhanced effectiveness and safety in the
artificial cornea transplant is more feasible and possible and this is expected
to support the further growth of the market in the upcoming five years.
Furthermore,
the population is more aware and informed about the availability of the
artificial cornea and corneal implants as a treatment procedure for the corneal
rupture, thereby supporting the growth of the market in the future five years.
Browse over XX
market data Figures spread through 70
Pages and an in-depth TOC on "United States Artificial Cornea and
Corneal Implants Market"
https://www.techsciresearch.com/report/united-states-artificial-cornea-and-corneal-implants-market/7994.html
The
United States artificial cornea and corneal implants market is segmented by
type, transplant type, disease indication, end user, competitional landscape,
and regional distribution. Based on disease indication, the market is further
bifurcated into Fuchs’ dystrophy, keratoconus, fungal keratitis, and others. Fuchs’
dystrophy is the eye disease, a condition in which fluid builds up in the
cornea, in the front of your eye, causing your cornea to swell and thicken.
This condition often leads to symptoms like glare, blurred or cloudy vision,
and eye discomforts.
Geriatric
population is more susceptible to the disease and thereby is anticipated to be
responsible for the growth of the segment in the future five years. Keratoconus
disease is a medical condition where the round shape of the eye is dismantled.
The cornea inside the eye loses its shape. The corneal layer thins and bulges
outward into a conical shape. The symptoms often first appear around puberty or
young adulthood that includes blurred vision and sensitivity toward the light.
Rising
number of the patient suffering from keratoconus often reach the stage where
they require corneal implant to regain their normal vision. Advanced procedures
like Deep Anterior Lamellar Keratoplasty (DALK) bestows the advantage, the
factor, along with FDA approved corneal implants are major drivers of the
market growth in the forecast period.
A
partial list of market player in the United States artificial cornea and
corneal implants market includes, Roche USA, Regeneron Pharmaceuticals, Inc,
Alcon, Inc., Bausch Health Companies, Inc., CorneaGen Inc., Bayer Corporation,
Addition Technology, Inc., among others. These market players hold larger
shares of the market than the new market players.
With
the advancement of the technology, it is appropriate to say that the effective
research and development of the technologically advanced medical devices would
support the market growth and benefit the market players as well as the
consumers. New market players may focus on the research and development to
provide devices that satisfies the consumer demand as well as benefits the
market players in building their brand value. Other competitive strategies
include mergers & acquisitions and new product developments.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7994
Customers can also request for 10% free
customization on this report.
“United
States supports a world-class healthcare facility that makes sure that the
citizen along with any other patient is provided with the best possible
healthcare benefits. With the increased number of hospitals, ambulatory care
centers, ophthalmological clinics, etc. the benefits provided is more
convenient and that is providing benefits to a greater number of patients. The
surge in demand due to the availability of such healthcare facility is expected
to be driving the growth of the market. New market players may invest in better
research and development of the implants and ophthalmic surgical devices to
establish their brand in the market. Aggressive advertisement and brand
building would aid the market players in the future market,” said Mr. Karan
Chechi, Research Director with TechSci Research, a research based global
management consulting firm.
“United States Artificial Cornea and Corneal
Implants Market By Type (Human Cornea v/s Artificial Cornea) By Transplant Type
(Penetrating Keratoplasty v/s Endothelial Keratoplasty) By Disease Indication
(Fuchs’ Dystrophy, Keratoconus, Fungal Keratitis, Others) By End User
(Hospitals, Ambulatory Care Centers, Others) By Region, Competition Forecast
& Opportunities, 2026” has evaluated the
future growth potential of United States Artificial Cornea and Corneal Implants
market and provides statistics & information on market size, structure and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in United States Artificial
Cornea and Corneal Implants market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel:
+1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com/